Form 4 Tracker
Immunovant, Inc.
IMVT

45 insider filings · Latest: Oct 7, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Feb 25, 2026Feb 27 9:07 PMMelanie GloriaChief Operating Officer
Sale
3,238$27.85$90.2K170,273(D)

View →

Feb 10, 2026Feb 10 10:16 PMMICHAEL GEFFNER
Proposed Sale
5,800$26.77$155.2K—

View →

Jan 21, 2026Jan 23 9:21 PMJay S StoutChief Technology Officer
Sale
1,977$26.03$51.5K197,634(D)

View →

Dec 1, 2025Dec 1 9:35 PMANDREW J FROMKIN
Proposed Sale
22,249$24.15$537.3K—

View →

Dec 1, 2025Dec 1 9:34 PMDOUGLAS HUGHES
Proposed Sale
15,000$24.15$362.3K—

View →

Nov 26, 2025Nov 26 10:07 PMMICHAEL GEFFNER
Proposed Sale
50,000$23.70$1.2M—

View →

Nov 25, 2025Nov 26 12:16 AMMICHAEL GEFFNER
Proposed Sale
103,897$23.38$2.4M—

View →

Jun 25, 2025Jun 25 8:02 PMWILLIAM MACIAS
Proposed Sale
30,000$15.83$474.9K—

View →

Jun 13, 2025Jun 13 9:34 PMWILLIAM MACIAS
Proposed Sale
50,000$15.57$778.5K—

View →

Jun 3, 2025Jun 3 9:42 PMWILLIAM MACIAS
Proposed Sale
80,000$15.61$1.2M—

View →

May 21, 2025May 21 8:24 PMGEORGE V MIGAUSKY
Proposed Sale
21,812$14.58$318.0K—

View →

May 19, 2025May 19 8:40 PMGEORGE V MIGAUSKY
Proposed Sale
28,188$14.58$410.9K—

View →

Mar 7, 2025Mar 7 9:17 PMANDREW J FROMKIN
Proposed Sale
8,000$19.52$156.2K—

View →

Feb 14, 2025Feb 14 9:11 PMMARK S LEVINE
Proposed Sale
69,763$20.16$1.4M—

View →

Feb 11, 2025Feb 11 9:11 PMMARK S LEVINE
Proposed Sale
29,196$19.54$570.4K—

View →

Dec 2, 2024Dec 2 9:33 PMDOUGLAS J. HUGHES
Proposed Sale
5,425$28.20$153.0K—

View →

Dec 2, 2024Dec 2 9:33 PMATUL CHANDRA PANDE
Proposed Sale
7,750$28.20$218.6K—

View →

← Previous

Page 3 of 3

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Apr 7, 2026Apr 9 8:10 PMTiago GiraoChief Financial Officer
Grant/Award
94,002$24.6194,002(D)

View →

Apr 1, 2026Apr 3 8:33 PMEric VenkerDirector, Chief Executive Officer
Option Exercise
368,750—1,106,250(D)

View →

← Previous

Page 2 of 2